SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 188 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $286,000 | -25.1% | 30,000 | +20.0% | 0.54% | +69.3% |
| Q2 2014 | $382,000 | +74.4% | 25,000 | +106.6% | 0.32% | +65.1% |
| Q1 2014 | $219,000 | -31.3% | 12,100 | -60.2% | 0.20% | -51.9% |
| Q3 2013 | $319,000 | -19.0% | 30,400 | -39.7% | 0.40% | -18.8% |
| Q2 2013 | $394,000 | – | 50,400 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,032,980 | $12,950,000 | 1.82% |
| EcoR1 Capital, LLC | 2,308,079 | $14,702,000 | 1.54% |
| Alexandria Capital, LLC | 1,005,119 | $6,403,000 | 1.05% |
| Casdin Capital, LLC | 1,455,000 | $9,268,000 | 0.98% |
| Rhenman & Partners Asset Management AB | 700,000 | $4,459,000 | 0.62% |
| Bellevue Group AG | 3,850,000 | $24,525,000 | 0.48% |
| GREAT POINT PARTNERS LLC | 633,505 | $4,035,000 | 0.42% |
| WASATCH ADVISORS LP | 5,938,434 | $37,828,000 | 0.39% |
| 361 CAPITAL LLC | 109,161 | $695,000 | 0.32% |
| Ceeto Capital Group, LLC | 50,000 | $319,000 | 0.26% |